Find Research Outputs

Search in all content

Filters for Scholarly Output

Search concepts
Selected Filters

Publication Year

  • 2018
  • 2017
  • 2016

Author

  • Joseph Patrick McEvoy
2018

Adjunct Aripiprazole Reduces Prolactin and Prolactin-Related Adverse Effects in Premenopausal Women with Psychosis: Results from the DAAMSEL Clinical Trial

Kelly, D. L., Powell, M. M., Wehring, H. J., Sayer, M. A., Kearns, A. M., Hackman, A. L., Buchanan, R. W., Nichols, R. B., Adams, H. A., Richardson, C. M., Vyas, G., McMahon, R. P., Earl, A. K., Sullivan, K. M., Liu, F., Luttrell, S. E., Dickerson, F. B., Feldman, S. M., Narang, S., Koola, M. M. & 3 others, Buckley, P. F., Rachbeisel, J. A. & McEvoy, J. P., Aug 1 2018, In : Journal of Clinical Psychopharmacology. 38, 4, p. 317-326 10 p.

Research output: Contribution to journalArticle

5 Scopus citations

Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels

Wehring, H. J., Elsobky, T., McEvoy, J. P., Vyas, G., Richardson, C. M., McMahon, R. P., DiPaula, B. A., Liu, F., Sullivan, K., Buchanan, R. W., Feldman, S., McMahon, E. M. & Kelly, D. L., Mar 1 2018, In : Psychiatric Quarterly. 89, 1, p. 73-80 8 p.

Research output: Contribution to journalArticle

8 Scopus citations

Evidence-Based Strategies for Managing Tardive Dyskinesia

McEvoy, J. P., Jan 1 2018, In : The Journal of clinical psychiatry. 79, 1

Research output: Contribution to journalArticle

11 Scopus citations

Revisiting the abnormal involuntary movement scale: Proceedings from the tardive dyskinesia assessment workshop

Kane, J. M., Correll, C. U., Nierenberg, A. A., Caroff, S. N., Sajatovic, M., Cutler, A. J., McEvoy, J. P. & Stacy, M., May 1 2018, In : Journal of Clinical Psychiatry. 79, 3, 17cs11959.

Research output: Contribution to journalArticle

13 Scopus citations

What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options

Manning, J. S. & McEvoy, J. P., Jan 1 2018, In : The Journal of clinical psychiatry. 79, 1

Research output: Contribution to journalArticle

1 Scopus citations
2017

Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial

Anderson, K. E., Stamler, D., Davis, M. D., Factor, S. A., Hauser, R. A., Isojärvi, J., Jarskog, L. F., Jimenez-Shahed, J., Kumar, R., McEvoy, J. P., Ochudlo, S., Ondo, W. G. & Fernandez, H. H., Aug 2017, In : The Lancet Psychiatry. 4, 8, p. 595-604 10 p.

Research output: Contribution to journalArticle

80 Scopus citations

Durability of therapeutic response with long-term aripiprazole lauroxil treatment following successful resolution of an acute episode of Schizophrenia

McEvoy, J. P., Risinger, R., Mykhnyak, S., Du, Y., Liu, C. C., Stanford, A. D. & Weiden, P. J., Sep 1 2017, In : Journal of Clinical Psychiatry. 78, 8, p. 1103-1109 7 p.

Research output: Contribution to journalArticle

6 Scopus citations

Prioritizing Harm

Moyer, K. H., McEvoy, J. P., Mabe, P. A., Buchanan, E., Venkatesan, A. & Buckley, P. F., Jan 2 2017, In : Journal of Personality Assessment. 99, 1, p. 78-82 5 p.

Research output: Contribution to journalArticle

2 Scopus citations

What's new in our understanding of schizophrenia

McEvoy, J. P., Feb 2017, In : Psychiatric Times. 34, 2

Research output: Contribution to journalArticle

2016

A guide to the management of clozapine-related tolerability and safety concerns

Citrome, L., McEvoy, J. P. & Saklad, S. R., Sep 1 2016, In : Clinical Schizophrenia and Related Psychoses. 10, 3, p. 163-177D

Research output: Contribution to journalReview article

28 Scopus citations

Brexpiprazole for the treatment of schizophrenia: A review of this novel serotonin-dopamine activity modulator

McEvoy, J. P. & Citrome, L., Dec 1 2016, In : Clinical Schizophrenia and Related Psychoses. 9, 4, p. 177-186 10 p.

Research output: Contribution to journalReview article

14 Scopus citations

Cost-effectiveness of long-acting injectable paliperidone palmitate versus haloperidol decanoate in maintenance treatment of schizophrenia

Rosenheck, R. A., Leslie, D. L., Sint, K. J., Lin, H., Li, Y., McEvoy, J. P., Byerly, M. J., Hamer, R. M., Swartz, M. S. & Stroup, T. S., Oct 1 2016, In : Psychiatric Services. 67, 10, p. 1124-1130 7 p.

Research output: Contribution to journalArticle

8 Scopus citations

Placebo controls in clinical trials: concerns about use in relapse prevention studies in schizophrenia

Emsley, R., Fleischhacker, W. W., Galderisi, S., Halpern, L. J., McEvoy, J. P. & Schooler, N. R., Sep 9 2016, In : BMJ (Clinical research ed.). 354, p. i4728

Research output: Contribution to journalArticle

2 Scopus citations

The RAISE connection program: Psychopharmacological treatment of people with a first episode of schizophrenia

Kreyenbuhl, J. A., Medoff, D. R., McEvoy, J. P., Smith, T. E., Hackman, A. L., Nossel, I. R., Dixon, L. B., Essock, S. M. & Buchanan, R. W., Dec 1 2016, In : Psychiatric Services. 67, 12, p. 1300-1306 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

To the Editor

McEvoy, J. P., Oct 1 2016, In : JAMA Psychiatry. 73, 10, p. 1097-1098 2 p.

Research output: Contribution to journalLetter

3 Scopus citations